PURPOSE: Sinus node dysfunction (SND) may complicate thoracoscopic surgical atrial fibrillation (AF) ablation. Identifying patients at risk is important, as SND may require temporary or permanent pacing. To determine the incidence of postoperative SND and duration of symptoms in patients who underwent thoracoscopic surgical ablation. METHODS:Patients with paroxysmal or persistent AF included in the Atrial Fibrillation Ablation and Autonomic Modulation via Thoracoscopic Surgery (AFACT) study underwent pulmonary vein isolation and additional left atrial ablations on indication. Patients were randomized to ganglion plexus ablation or control. SND was defined as symptomatic or asymptomatic junctional rhythm exceeding sinus rate within 30 days postoperatively. The SND risk was assessed by using a univariable logistic regression model. The rate of pacemaker implantation was determined. RESULTS: The AFACT study included 240 patients. SND developed in 17 (7.1%) patients, not affected by randomized treatment, p = 0.18. SND patients more often had persistent AF (88.2%) than patients without SND (57.4%), p = 0.01. After univariable testing, persistent AF (OR 5.57 CI 1.52-35.90, p = 0.02) and additional left atrial ablations (OR 12.10 CI 2.40-220.20, p = 0.02) were associated with postoperative SND. Six (35.3%) patients needed temporary pacing for 1-7 days; permanent pacemakers (PMs) were implanted for SND in five (29.4%) patients. CONCLUSION:Additional left atrial ablations strongly increase the SND risk. The majority of SND was temporary, and sinus rhythm resolved within days, which indicates that a conservative approach with regard to pacemaker implantation should be considered.
RCT Entities:
PURPOSE:Sinus node dysfunction (SND) may complicate thoracoscopic surgical atrial fibrillation (AF) ablation. Identifying patients at risk is important, as SND may require temporary or permanent pacing. To determine the incidence of postoperative SND and duration of symptoms in patients who underwent thoracoscopic surgical ablation. METHODS:Patients with paroxysmal or persistent AF included in the Atrial Fibrillation Ablation and Autonomic Modulation via Thoracoscopic Surgery (AFACT) study underwent pulmonary vein isolation and additional left atrial ablations on indication. Patients were randomized to ganglion plexus ablation or control. SND was defined as symptomatic or asymptomatic junctional rhythm exceeding sinus rate within 30 days postoperatively. The SND risk was assessed by using a univariable logistic regression model. The rate of pacemaker implantation was determined. RESULTS: The AFACT study included 240 patients. SND developed in 17 (7.1%) patients, not affected by randomized treatment, p = 0.18. SNDpatients more often had persistent AF (88.2%) than patients without SND (57.4%), p = 0.01. After univariable testing, persistent AF (OR 5.57 CI 1.52-35.90, p = 0.02) and additional left atrial ablations (OR 12.10 CI 2.40-220.20, p = 0.02) were associated with postoperative SND. Six (35.3%) patients needed temporary pacing for 1-7 days; permanent pacemakers (PMs) were implanted for SND in five (29.4%) patients. CONCLUSION: Additional left atrial ablations strongly increase the SND risk. The majority of SND was temporary, and sinus rhythm resolved within days, which indicates that a conservative approach with regard to pacemaker implantation should be considered.
Authors: Sébastien P J Krul; Antoine H G Driessen; Aeilko H Zwinderman; Wim J van Boven; Arthur A M Wilde; Jacques M T de Bakker; Joris R de Groot Journal: Int J Cardiol Date: 2011-11-09 Impact factor: 4.164
Authors: Sébastien P J Krul; Antoine H G Driessen; Wim J van Boven; André C Linnenbank; Guillaume S C Geuzebroek; Warren M Jackman; Arthur A M Wilde; Jacques M T de Bakker; Joris R de Groot Journal: Circ Arrhythm Electrophysiol Date: 2011-04-14
Authors: Larry R Jackson; Bharath Rathakrishnan; Kristen Campbell; Kevin L Thomas; Jonathan P Piccini; Tristram Bahnson; Jonathan A Stiber; James P Daubert Journal: Pacing Clin Electrophysiol Date: 2017-03-08 Impact factor: 1.976
Authors: Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas Journal: Eur Heart J Date: 2016-08-27 Impact factor: 29.983
Authors: Antoine H G Driessen; Wouter R Berger; Sébastien P J Krul; Nicoline W E van den Berg; Jolien Neefs; Femke R Piersma; Dean R P P Chan Pin Yin; Jonas S S G de Jong; WimJan P van Boven; Joris R de Groot Journal: J Am Coll Cardiol Date: 2016-09-13 Impact factor: 24.094
Authors: Timo Weimar; Stefano Schena; Marci S Bailey; Hersh S Maniar; Richard B Schuessler; James L Cox; Ralph J Damiano Journal: Circ Arrhythm Electrophysiol Date: 2011-11-17
Authors: Sébastien P J Krul; Wouter R Berger; Nicoline W Smit; Shirley C M van Amersfoorth; Antoine H G Driessen; Wim Jan van Boven; Jan W T Fiolet; Antoni C G van Ginneken; Allard C van der Wal; Jacques M T de Bakker; Ruben Coronel; Joris R de Groot Journal: Circ Arrhythm Electrophysiol Date: 2015-02-11
Authors: Prashanthan Sanders; Joseph B Morton; Peter M Kistler; Steven J Spence; Neil C Davidson; Azlan Hussin; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman Journal: Circulation Date: 2004-03-08 Impact factor: 29.690
Authors: Jolien Neefs; Robin Wesselink; Nicoline W E van den Berg; Jonas S S G de Jong; Femke R Piersma; WimJan P van Boven; Antoine H G Driessen; Joris R de Groot Journal: J Interv Card Electrophysiol Date: 2021-09-16 Impact factor: 1.759